22.22  0.49 (2.25%)		07-18 16:00
Open: 22.22 High: 22.275 Volume: 1,893,533		Pre. Close: 21.73 Low: 21.24 Market Cap: 317(M)

Short term
Mid term
Targets	6-month :	27.81	1-year :	33.6
Resists	First :	23.81	Second :	28.77
Pivot price	19.99
Supports	First :	15.8	Second :	13.14
MAs	MA(5) :	21.4	MA(20) :	19.62
	MA(100) :	8.19	MA(250) :	0
MACD	MACD :	2.2	Signal :	2.4
%K %D	K(14,3) :	42.5	D(3) :	46
RSI	RSI(14): 77.1
52-week	High :	28.77	Low :	1.32

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ PTHL ] has closed below upper band by 6.9%. Bollinger Bands are 19% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	22.3 - 22.39	22.39 - 22.47
Low:	21.02 - 21.12	21.12 - 21.22
Close:	22.05 - 22.21	22.21 - 22.37

Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system is FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was founded in 1998 and is based in Beijing, China. Pheton Holdings Ltd operates as a subsidiary of ZJW (BVI) LTD.

Sat, 10 May 2025
Leerink Partnrs Has Strong Forecast for Zoetis Q3 Earnings - Defense World

Thu, 05 Sep 2024
Pheton Holdings Ltd Announces Pricing of Initial Public Offering - GlobeNewswire

Thu, 12 Oct 2023
Pheton Holdings Pursues U.S. Micro-IPO (Pending:PTHL) - Seeking Alpha

Sun, 20 Jul 2025

Sun, 20 Jul 2025

Sun, 20 Jul 2025

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	7 (M)
Shares Float	0 (M)
Held by Insiders	95.1 (%)
Held by Institutions	0.2 (%)
Shares Short	121 (K)
Shares Short P.Month	54 (K)

EPS	-0.06
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.43
Profit Margin	-147.4 %
Operating Margin	-191.9 %
Return on Assets (ttm)	-11.6 %
Return on Equity (ttm)	-20.4 %
Qtrly Rev. Growth	-34.3 %
Gross Profit (p.s.)	0.05
Sales Per Share	0.06
EBITDA (p.s.)	-0.12
Qtrly Earnings Growth	0 %
Operating Cash Flow	-1 (M)
Levered Free Cash Flow	-1 (M)

PE Ratio	-444.4
PEG Ratio	0
Price to Book value	51.67
Price to Sales	326.21
Price to Cash Flow	-188.66

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.